In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roussel Uclaf

Division of Sanofi

Latest From Roussel Uclaf

Sanofi CSO David-Alexandre Gros On The Next Wave Of Growth In Emerging Markets: An Interview With PharmAsia News

During a visit to Shanghai, Sanofi’s chief strategy officer sits down to talk about the company’s playbook for emerging markets, which focuses on both the BRIC countries and up-and-coming markets like Vietnam, Colombia and Nigeria.

BioPharmaceutical China

AZ Taps Outsider Soriot As CEO, While Roche Anoints 25-Year Veteran O'Day To Head Pharma Division

AstraZeneca has appointed an experienced biotech and pharmaceuticals executive, Pascal Soriot, to its vacant CEO position, while Roche switches Daniel O'Day from its diagnostics to its pharmaceuticals division.

BioPharmaceutical Europe

DRUG RECALL DATA FOR 1997

...show a resurgence in recalls related to application integrity issues. Potency problems continue to be the source of a high percentage of recalls. Overall, the number and types of drug product recalls reported in 1997 are in line with the 1996 tally. Labeling/packaging recalls are an exception, more than doubling from the prior year. Comments on a proposed cGMP rule modifying the cut labeling provisions are under review at FDA. Recalls of injectables also spike in 1997. FDA considers four drug recalls involving various dosage forms and one therapeutic biological recall dangerous enough to warrant a Class I rating. [A nine-page tabulation of recalls listed in FDA "Enforcement Reports" during 1997 is included.]
BioPharmaceutical
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Sanofi
  • Senior Management
  • J. P Godard, CEO
    D. Camus, CFO
    J. Raynaud, Dir., Research
  • Contact Info
  • Roussel Uclaf
    Phone: (33) 1 40 62 4062
    35, Boulevard des Invalides
    Paris, 75007-
    France
Advertisement
Advertisement
UsernamePublicRestriction

Register